Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition

References

• Constantinides PP, Chaubal MV, Shorr R. (2008). Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev, 60:757–767.
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. (2009). Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm, 71:161–172.
   PubMed Web of Science ®Google Scholar
• Müller RH, Souto EB, Göppert T, Gohla S. (2005). Production of biofunctionalized solid lipid nanoparticles for site-specific drug delivery. In: Kumar CSSR (ed.), Biological and Pharmaceutical Nanomaterials (Nanotecnologies for the Life Sciences). Wiley-VCH, pp. 291–307.
   Google Scholar
• Wissing SA, Kayser O, Müller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev, 56:1257–1272.
   PubMed Web of Science ®Google Scholar
• SinglaAK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm, 235:179–192.
   PubMed Web of Science ®Google Scholar
• Patravale VB, Ambarkhane AV. (2003). Study of solid lipid nanoparticles with respect to particle size distribution and drug loading. Pharmazie, 58:392–395.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Williams RO 3rd. (2008). CNS disorders–current treatment options and the prospects for advanced therapies. Drug Dev Ind Pharm, 34:1141–1167.
   PubMed Web of Science ®Google Scholar
• Göppert TM, Müller RH. (2005). Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target, 13:179–187.
   PubMed Web of Science ®Google Scholar
• Werle M. (2008). Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm Res, 25:500–511.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm, 50:161–177.
   PubMed Web of Science ®Google Scholar
• Lockman PR, Mumper RJ, Khan MA, Allen DD. (2002). Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm, 28:1–13.
   PubMed Web of Science ®Google Scholar
• Kerwin BA. (2008). Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. j Pharm Sci, 97:2924–2935.
   PubMed Web of Science ®Google Scholar
• Brandl M, Bachmann D, Drechsler M, Bauer KH. (1990). Liposome Preparation by a new High Pressure Homogenizer Gaulin Micron Lab 40. Drug Dev Ind Pharm, 16,2167–2191.
   Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH. (2008). Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm, 34:1394–1405.
   PubMed Web of Science ®Google Scholar
• Rosenblatt KM, Bunjes H. (2009). Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the α-modification. Mol Pharm, 6,105–120.
   PubMed Web of Science ®Google Scholar
• Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. (2009). Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci, 334:75–81.
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT, Fang JY. (2010). Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm, 36:751–761.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. (2008). Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm, 70:75–84.
   PubMed Web of Science ®Google Scholar
• Petri B, Bootz A, Khalansky A, Hekmatara T, Müller R, Uhl R et al. (2007). Chemotherapy of brain tumor using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release, 117:51–58.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. (2008). Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release, 130:98–106.
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. (1999). Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm, 47:125–132.
   PubMed Web of Science ®Google Scholar
• Driscoll DF. (2006). Lipid injectable emulsions: Pharmacopeial and safety issues. Pharm Res, 23:1959–1969.
   PubMed Web of Science ®Google Scholar
• Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B et al. (2008). Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Deliv Rev, 60:939–954.
   PubMed Web of Science ®Google Scholar
• Frantzen CB, Ingebrigtsen L, Skar M, Brandl M. (2003). Assessing the accuracy of routine photon correlation spectroscopy analysis of heterogeneous size distributions. AAPS Pharmscitech, 4:E36.
   PubMedGoogle Scholar
• Driscoll D. (2002). The significance of particle/globule-sizing measurements in the safe use of intravenous lipid emulsions. J Dispers Sci Technol, 23,679.
   Web of Science ®Google Scholar
• Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC et al. (2008). Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials, 29:1509–1517.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gohla S. (2000). Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int J Pharm, 196:219–222.
   PubMed Web of Science ®Google Scholar
• Müller RH, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev, 47:3–19.
   PubMed Web of Science ®Google Scholar
• Lockman PR, Koziara JM, Mumper RJ, Allen DD. (2004). Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target, 12:635–641.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R. (2008). Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res, 25:2262–2271.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Unruh T. (2007). Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev, 59:379–402.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Müller-Goymann CC. (2005). Characterization of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm, 61:77–86.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Drechsler M, Koch MH, Westesen K. (2001). Incorporation of the model drug ubidecarenone into solid lipid nanoparticles. Pharm Res, 18:287–293.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Koch MH, Westesen K. (2003). Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J Pharm Sci, 92:1509–1520.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Koch MHJ, Westesen K. (2000). Effect of particle size on colloidal solid triglycerides. Langmuir, 16,5234–5241.
   Web of Science ®Google Scholar
• Kuntsche J, Bunjes H. (2007). Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles. Eur J Pharm Biopharm, 67:612–620.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Siekmann B, Westesen K. (1998). Emulsions of supercooled melts - a novel drug delivery system. In: Benita, ed. Submicron Emulsions in Drug Targeting and Delivery. Amsterdam: Harwood Academic Publishers, 175–218.
   Google Scholar
• Kuntsche J, Westesen K, Drechsler M, Koch MH, Bunjes H. (2004). Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs. Pharm Res, 21:1834–1843.
   PubMed Web of Science ®Google Scholar